Reduced serum Gc-globulin concentrations in patients with fulminant hepatic failure: Association with multiple organ failure

Critical Care Medicine

Volumn 25, Issue 8, 1997, Pages 1366-1370

  Schiødt, Frank Vinholt ^a   Ott, Peter ^a   Bondesen, Stig ^a   Tygstrup, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Actin; Actin scavenger system; Fulminant hepatic failure; Gc globulin; Multiple organ failure; Pathogenesis

Indexed keywords

VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEART FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LIVER FAILURE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEART FAILURE, CONGESTIVE; HEPATIC ENCEPHALOPATHY; HUMANS; INFECTION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSEUDOTUMOR CEREBRI; REPRODUCIBILITY OF RESULTS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAMIN D-BINDING PROTEIN;

EID: 0030787881     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199708000-00025     Document Type: Article

References (32)

1. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. JAMA 1994; 271:226-233
2. Trey C, Davidson CS: The management of fulminant hepatic failure. In: Progress in Liver Diseases. Vol III. Popper H, Schaffner F (Eds). New York, Grune & Stratton, 1970, pp 282-298
3. Atillasoy E, Berk PD: Fulminant hepatic failure: Pathophysiology, treatment and survival. Annu Rev Med 1995; 46:181-191
4. Muñoz SJ: Difficult management problems in fulminant hepatic failure. Semin Liver Dis 1993; 13:395-413
5. Lee WM: Acute liver failure. N Engl J Med 1993; 329:1862-1872
6. Anonymous: The brain in fulminant hepatic failure. Lancet 1991; 338: 156-157
7. Rolando N, Harvey F, Brahm J, et al: Prospective study of bacterial infection in acute liver failure: An analysis of 50 patients. Hepatology 1990; 11:49-53
8. Lee WM, Galbraith RM: The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-1341
9. Stossel TP: From signal to pseudopod: How cells control cytoplasmic actin assembly. J Biol Chem 1989; 264: 18261-18264
10. Haddad JD, Harper KD, Guoth M, et al: Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A 1990; 87:1381-1385
11. Kwiatkowski DJ, Mehl R, Izumo S, et al: Muscle is the major source of plasma gelsolin. J Biol Chem 1988; 263: 8239-8243
12. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, et al: Accurate quantitation of native Gc protein in serum and estimation of endogenous Gc:G-actin complexes by rocket immunoelectrophoresis. Clin Chim Acta. 1985; 148:173-183
13. Dueland S, Nenseter MS, Drevon CA: Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat. Biochem J 1991; 274:237-241
14. Lee WM, Galbraith RM, Watt GH, et al: Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 1995; 21:101-105
15. Schiødt FV, Bondesen S, Petersen I, et al: Admission levels of serum Gc-globulin: Predictive value in fulminant hepatic failure. Hepatology 1996; 23: 713-718
16. Spanier TB, Klein RD, Nasraway SA, et al: Multiple organ failure after liver transplantation. Crit Care Med 1995; 23:466-473
17. Goka AKJ, Wendon JA, Williams R: Fulminant hepatic failure, endogenous endotoxemia, and multiple systems organ failure. In: Multiple Systems Organ Failure: Hepatic Regulation of Systemic Host Defense. Matuschack GM (Ed). New York, Marcel Dekker, 1993, pp 215-228
18. Roumen RMH, Sehers TJ, de Boer HHM, et al: Scoring systems for predicting outcome in acute hemorrhagic necrotizing pancreatitis. Eur J Surg 1992; 158:167-171
19. Schiødt FV, Bondesen S, Tygstrup N: Serial measurements of plasma Gc-globulin in acetaminophen intoxication. Eur J Gastroenterol Hepatol 1995; 7:635-640
20. Bihari D, Gimson AE, Waterson M, et al: Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985; 13:1034-1039
21. Bihari D, Gimson A, Lindridge J, et al: Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol 1985; 1:405-416
22. Williams MH, Van Alstyne EL, Galbraith RM: Evidence of a novel association unsaturated fatty acids with Gc (vitamin D-binding protein). Biochem Biophys Res Commun 1988; 153:1019-1024
23. Calvo M, Ena JM: Relations between vitamin D and fatty acid binding properties of vitamin D-binding protein. Biochem Biophys Res Commun 1989; 163:14-17
24. Cook JA, Wise WC, Knapp DR, et al: Essential fatty acid deficient rats: A new model for evaluating arachidonate metabolism in shock. Adv Shock Res 1985; 6:93-105
25. Robbins RA, Hamel FG: Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a. J Immunol 1990; 144:2371-2376
26. Perez HD: Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: An explanation for its cochemotaxin activity. Inflammation 1994; 18: 215-220
27. Chujo T, Machii T, Tagawa S, et al: Inhibition of human natural killer activity by antiserum against vitamin D-binding protein, a group-specific component (Gc). Clin Exp Immunol 1989; 76: 154-158
28. Berger D, Winter M, Beger HG: Influence of human transferrin and group-specific protein on endotoxicity in vitro. Clin Chim Acta 1990; 189:1-5
29. 3 binding protein (group specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci U S A 1991; 88:8539-8543
30. Lee WM, Reines D, Watt GH, et al: Alterations in Gc levels and complexing in septic shock. Circ Shock 1989; 28: 249-255
31. Parrillo JE: Mechanisms of disease: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477
32. Guha C, Osawa M, Werner PA, et al: Regulation of human Gc (vitamin D-binding) protein levels: Hormonal and cytokine control of gene expression in vitro. Hepatology 1995; 21:1675-1681